<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04844957</url>
  </required_header>
  <id_info>
    <org_study_id>2021A-057</org_study_id>
    <nct_id>NCT04844957</nct_id>
  </id_info>
  <brief_title>Clinical Study of the Effect of Vitamin D on the RAAS System in Children With Chronic Orthostatic Intolerance (POTS)</brief_title>
  <acronym>CSOPOTS</acronym>
  <official_title>Clinical Study of the Effect of Vitamin D on the RAAS System in Children With Chronic Orthostatic Intolerance (POTS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kongyujie</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>LanZhou University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>LanZhou University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      chronic orthostatic intolerance in children；postural tachycardia syndrome；vitamin&#xD;
      D；RAAS；atecholamines&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      children with chronic orthostatic intolerance (Postural tachycardia syndrome, POTS) have a&#xD;
      long course of disease, which seriously affects children's physical and mental health and&#xD;
      quality of life, and the incidence rate is also increasing year by year. But the current&#xD;
      treatment measures are not ideal, Therefore, we need to look for new biological indicators,&#xD;
      according to different biological indicators to develop different treatment options, so as to&#xD;
      improve the current situation of poor treatment of children with POTS.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 20, 2020</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 20, 2021</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D levels</measure>
    <time_frame>3 months after taking the drug</time_frame>
    <description>Vitamin D levels after supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>RAAS levels</measure>
    <time_frame>3 months after taking the drug</time_frame>
    <description>RAAS levels after vitamin D supplementation</description>
  </secondary_outcome>
  <other_outcome>
    <measure>OI symptom scores</measure>
    <time_frame>3 months after taking the drug</time_frame>
    <description>OI symptom scores after vitamin D supplementation</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Vitamin D</condition>
  <arm_group>
    <arm_group_label>Clinical Study of Vitamin D in Children With (POTS)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Clinical Study of the Effect of Vitamin D on the RAAS System in Children With Chronic Orthostatic Intolerance (POTS)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D</intervention_name>
    <description>Clinical Study</description>
    <arm_group_label>Clinical Study of Vitamin D in Children With (POTS)</arm_group_label>
    <other_name>Vitamin D drops</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Full automatic chemiluminescence measuring instrument</intervention_name>
    <description>Chemiluminescence immunoassay</description>
    <arm_group_label>Clinical Study of Vitamin D in Children With (POTS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children diagnosed with POTS ;&#xD;
&#xD;
          -  Compliance with the diagnostic guidelines for Syncope in children (2016 edition) and&#xD;
             2018 syncope in children and adolescents in the cardiovascular group of the Society of&#xD;
             Pediatrics, Chinese Medical Association The diagnostic criteria of Oi in the&#xD;
             Diagnostic and therapeutic guidelines.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taken 3 months prior to admission Vitamin D or hormone drugs;&#xD;
&#xD;
          -  Heart, brain, nerves, metabolism, blood and other apparatus Syncope or aura of syncope&#xD;
             caused by a qualitative disease;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>xiangyu Dong, Professor</last_name>
    <role>Study Director</role>
    <affiliation>LanZhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>yujie Kong, M.D</last_name>
    <phone>18709316966</phone>
    <email>13523396714@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>xiangyu Dong, Professor</last_name>
    <phone>13609370003</phone>
    <email>dxy0223@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Kongyujie</name>
      <address>
        <city>Lanzhou</city>
        <state>Gansu</state>
        <zip>733000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>yujie Kong, M.D</last_name>
      <phone>18709316966</phone>
      <email>13523396714@163.com</email>
    </contact>
    <contact_backup>
      <last_name>xiangyu Dong, Professor</last_name>
      <phone>13609370003</phone>
      <email>dxy0223@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 28, 2021</study_first_submitted>
  <study_first_submitted_qc>April 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 14, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>LanZhou University</investigator_affiliation>
    <investigator_full_name>Kongyujie</investigator_full_name>
    <investigator_title>Graduate student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Orthostatic Intolerance</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Vitamins</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Experimental outcomes</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

